Home » Topics » Regulatory

Regulatory
RSS

GlaxoSmithKline's Pandemrix H1N1 vaccine approved in Europe

Oct. 1, 2009

FDA grants accelerated approval to Allos Therapeutics' Folotyn for relapsed or refractory PTCL

Sep. 28, 2009

Abbott receives FDA approval for HIV-1/HIV-2 blood screening test

Sep. 25, 2009

Sabril launched in U.S. for patients with difficult-to-treat epilepsy

Sep. 25, 2009

FDA approves Valturna, a single-pill combination of aliskiren and valsartan

Sep. 18, 2009

Theravance and Astellas obtain FDA approval of Vibativ

Sep. 16, 2009

Lumavita is granted marketing authorization in Switzerland for pentamycin for vaginitis

Sep. 1, 2009

FDA approves Embeda for moderate to severe chronic pain

Aug. 17, 2009

Saphris approved by FDA for schizophrenia and bipolar I disorder

Aug. 17, 2009

Invega approved for the treatment of schizoaffective disorder

Aug. 6, 2009